Arlene Stark

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies

Arlene Stark, Shaun Jordan, Kelly A. Allers et al. · Psychopharmacology · 2006 · 143 citations

Vivo Electrophysiological Studies, Neuropsychology, Psychoactive Drug +13

Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic

Yoshihiro Tadori, Takashi Miwa, Katsura Tottori et al. · European Journal of Pharmacology · 2005 · 85 citations

Psychoactive Drug, Psychiatry, Addiction +12

Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912

Yoshihiro Tadori, Hisashi Kitagawa, Robert A. Forbes et al. · European Journal of Pharmacology · 2007 · 65 citations

Molecular Pharmacology, Agonist/antagonist Properties, Psychiatry +8

Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions

Michael E. Trulson, Arlene Stark, Barry L. Jacobs · European Journal of Pharmacology · 1977 · 39 citations

Psychoactive Drug, Behavioral Neuroscience, Neuroanatomy +13

6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats

Harvey Wong, Randy Dockens, Lori Pajor et al. · Drug Metabolism and Disposition · 2007 · 36 citations